Literature DB >> 18516069

Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.

J Gierten1, E Ficker, R Bloehs, K Schlömer, S Kathöfer, E Scholz, E Zitron, C Kiesecker, A Bauer, R Becker, H A Katus, C A Karle, D Thomas.   

Abstract

BACKGROUND AND
PURPOSE: Two-pore-domain potassium (K2P) channels mediate potassium background (or 'leak') currents, controlling excitability by stabilizing membrane potential below firing threshold and expediting repolarization. Inhibition of K2P currents permits membrane potential depolarization and excitation. As expected for key regulators of excitability, leak channels are under tight control from a plethora of stimuli. Recently, signalling via protein tyrosine kinases (TKs) has been implicated in ion channel modulation. The objective of this study was to investigate TK regulation of K2P channels. EXPERIMENTAL APPROACH: The two-electrode voltage clamp technique was used to record K2P currents in Xenopus oocytes. In addition, K2P channels were studied in Chinese hamster ovary (CHO) cells using the whole-cell patch clamp technique. KEY
RESULTS: Here, we report inhibition of human K2P3.1 (TASK-1) currents by the TK antagonist, genistein, in Xenopus oocytes (IC50=10.7 microM) and in CHO cells (IC50=12.3 microM). The underlying molecular mechanism was studied in detail. hK2P3.1 was not affected by genistin, an inactive analogue of genistein. Perorthovanadate, an inhibitor of tyrosine phosphatase activity, reduced the inhibitory effect of genistein. Current reduction was voltage independent and did not require channel protonation at position H98 or phosphorylation at the single TK phosphorylation site, Y323. Among functional hK2P family members, genistein also reduced K2P6.1 (TWIK-2), K2P9.1 (TASK-3) and K2P13.1 (THIK-1) currents, respectively. CONCLUSIONS AND IMPLICATIONS: Modulation of K2P channels by the TK inhibitor, genistein, represents a novel molecular mechanism to alter background K+ currents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516069      PMCID: PMC2518462          DOI: 10.1038/bjp.2008.213

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  57 in total

Review 1.  Potassium leak channels and the KCNK family of two-P-domain subunits.

Authors:  S A Goldstein; D Bockenhauer; I O'Kelly; N Zilberberg
Journal:  Nat Rev Neurosci       Date:  2001-03       Impact factor: 34.870

2.  Block of Kcnk3 by protons. Evidence that 2-P-domain potassium channel subunits function as homodimers.

Authors:  C M Lopes; N Zilberberg; S A Goldstein
Journal:  J Biol Chem       Date:  2001-05-17       Impact factor: 5.157

Review 3.  Properties and modulation of mammalian 2P domain K+ channels.

Authors:  A J Patel; E Honoré
Journal:  Trends Neurosci       Date:  2001-06       Impact factor: 13.837

4.  Characterization of four types of background potassium channels in rat cerebellar granule neurons.

Authors:  Jaehee Han; Jeffrey Truell; Carmen Gnatenco; Donghee Kim
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

Review 5.  Cardiac channelopathies.

Authors:  Eduardo Marbán
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 6.  Cancer chemoprevention by dietary constituents: a tale of failure and promise.

Authors:  A J Gescher; R A Sharma; W P Steward
Journal:  Lancet Oncol       Date:  2001-06       Impact factor: 41.316

Review 7.  Genistein.

Authors:  Richard A Dixon; Daneel Ferreira
Journal:  Phytochemistry       Date:  2002-06       Impact factor: 4.072

8.  Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor.

Authors:  Andrea Barbuti; Satoshi Ishii; Takao Shimizu; Richard B Robinson; Steven J Feinmark
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

Review 9.  Lipid and mechano-gated 2P domain K(+) channels.

Authors:  A J Patel; M Lazdunski; E Honoré
Journal:  Curr Opin Cell Biol       Date:  2001-08       Impact factor: 8.382

10.  Dietary genistein inhibits metastasis of human prostate cancer in mice.

Authors:  Minalini Lakshman; Li Xu; Vijayalakshmi Ananthanarayanan; Joshua Cooper; Chris H Takimoto; Irene Helenowski; Jill C Pelling; Raymond C Bergan
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

View more
  25 in total

1.  PKC-dependent activation of human K(2P) 18.1 K(+) channels.

Authors:  Ann-Kathrin Rahm; Jakob Gierten; Jana Kisselbach; Ingo Staudacher; Kathrin Staudacher; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.

Authors:  C Seyler; E Duthil-Straub; E Zitron; J Gierten; E P Scholz; R H A Fink; C A Karle; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Acetylcholine-dependent upregulation of TASK-1 channels in thalamic interneurons by a smooth muscle-like signalling pathway.

Authors:  Michael Leist; Susanne Rinné; Maia Datunashvili; Ania Aissaoui; Hans-Christian Pape; Niels Decher; Sven G Meuth; Thomas Budde
Journal:  J Physiol       Date:  2017-08-03       Impact factor: 5.182

Review 4.  The life and death of breast cancer cells: proposing a role for the effects of phytoestrogens on potassium channels.

Authors:  Joanne L Wallace; Iain F Gow; Mary Warnock
Journal:  J Membr Biol       Date:  2011-07-05       Impact factor: 1.843

5.  In vivo and in vitro comparison of female and male nociceptors.

Authors:  Jan Hendrich; Pedro Alvarez; Elizabeth K Joseph; Luiz F Ferrari; Xiaojie Chen; Jon D Levine
Journal:  J Pain       Date:  2012-11-10       Impact factor: 5.820

6.  Macroporous hydrogel micropillars for quantifying Met kinase activity in cancer cell lysates.

Authors:  Alicia D Powers; Bi Liu; Andrew G Lee; Sean P Palecek
Journal:  Analyst       Date:  2012-07-20       Impact factor: 4.616

7.  The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.

Authors:  Jakob Gierten; Eckhard Ficker; Ramona Bloehs; Patrick A Schweizer; Edgar Zitron; Eberhard Scholz; Christoph Karle; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-24       Impact factor: 3.000

8.  Novel pharmacological approaches for antiarrhythmic therapy.

Authors:  Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-01-15       Impact factor: 3.000

9.  Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.

Authors:  J Jehle; E Ficker; X Wan; I Deschenes; J Kisselbach; F Wiedmann; I Staudacher; C Schmidt; P A Schweizer; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

10.  Effect of tyrphostin AG879 on Kv 4.2 and Kv 4.3 potassium channels.

Authors:  Haibo Yu; Beiyan Zou; Xiaoliang Wang; Min Li
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.